CAAS
BIIB icon

Capital Asset Advisory Services’s Biogen BIIB Stock Holding History

Capital Asset Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-351
Closed -$86K – 746
2020
Q4 		$86K Buy
+351
New +$90.5K 0.02% 492

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Asset Advisory Services's BIIB Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of Biogen (BIIB) in Q1 2021, closing a stake of 351 shares — an estimated $86K sold.

Capital Asset Advisory Services first reported a position in BIIB in Q4 2020 and held it in 1 quarter. The position peaked at $86K in Q4 2020. 1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 351 Biogen shares in Q1 2021, an estimated $86K.
  • Capital Asset Advisory Services first reported a position in Biogen in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's Biogen position peaked at $86K in Q4 2020.
  • 1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.